These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33607534)
1. Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. Ozkan T; Hekmatshoar Y; Karabay AZ; Koc A; Altinok Gunes B; Karadag Gurel A; Sunguroglu A Leuk Res; 2021 Mar; 102():106523. PubMed ID: 33607534 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells. Ozkan T; Hekmatshoar Y; Pamuk H; Ozcan M; Yaman G; Yagiz GC; Akdemir C; Sunguroglu A Mol Biol Rep; 2021 Feb; 48(2):1625-1631. PubMed ID: 33515349 [TBL] [Abstract][Full Text] [Related]
3. Some 2-[4-(1H-benzimidazol-1-yl) phenyl]-1H-benzimidazole derivatives overcome imatinib resistance by induction of apoptosis and reduction of P-glycoprotein activity. Hekmatshoar Y; Ozkan T; Alp M; Gurkan-Alp AS; Sunguroglu A Chem Biol Drug Des; 2023 Dec; 102(6):1521-1533. PubMed ID: 37722976 [TBL] [Abstract][Full Text] [Related]
5. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells. Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662 [TBL] [Abstract][Full Text] [Related]
6. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib. Yandim MK; Ceylan C; Elmas E; Baran Y Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734 [TBL] [Abstract][Full Text] [Related]
7. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
8. Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells. Liu J; Zhang Y; Liu A; Wang J; Li L; Chen X; Gao X; Xue Y; Zhang X; Liu Y Int J Mol Sci; 2016 Apr; 17(4):531. PubMed ID: 27070592 [TBL] [Abstract][Full Text] [Related]
9. Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance. Lee CR; Kang JA; Kim HE; Choi Y; Yang T; Park SG FEBS Lett; 2016 Feb; 590(3):358-68. PubMed ID: 26831735 [TBL] [Abstract][Full Text] [Related]
10. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro]. Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line. Hekmatshoar Y; Karadag Gurel A; Ozkan T; Rahbar Saadat Y; Koc A; Karabay AZ; Bozkurt S; Sunguroglu A Adv Med Sci; 2023 Sep; 68(2):238-248. PubMed ID: 37421850 [TBL] [Abstract][Full Text] [Related]
12. Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein. Liao HC; Chou YJ; Lin CC; Liu SH; Oswita A; Huang YL; Wang YL; Syu JL; Sun CM; Leu CM; Lin CH; Fu SL Biochem Pharmacol; 2019 May; 163():308-320. PubMed ID: 30822403 [TBL] [Abstract][Full Text] [Related]
13. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chen PH; Liu AJ; Ho KH; Chiu YT; Anne Lin ZH; Lee YT; Shih CM; Chen KC Chem Biol Interact; 2018 Aug; 291():144-151. PubMed ID: 29890129 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies. Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095 [TBL] [Abstract][Full Text] [Related]
15. Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells. Jiang L; Wen C; He Q; Sun Y; Wang J; Lan X; Rohondia S; Dou QP; Shi X; Liu J Eur J Pharmacol; 2020 Jun; 876():173064. PubMed ID: 32179085 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Baran Y; Ural AU; Gunduz U Hematology; 2007 Dec; 12(6):497-503. PubMed ID: 17852433 [TBL] [Abstract][Full Text] [Related]
17. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms. Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201 [TBL] [Abstract][Full Text] [Related]
18. CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation. Fang Z; Jung KH; Yan HH; Kim SJ; Son MK; Rumman M; Lee H; Kim KW; Yoo HD; Hong SS Int J Oncol; 2015 Jul; 47(1):253-61. PubMed ID: 25963192 [TBL] [Abstract][Full Text] [Related]
19. MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells. Wong SM; Liu FH; Lee YL; Huang HM PLoS One; 2016; 11(1):e0148093. PubMed ID: 26815740 [TBL] [Abstract][Full Text] [Related]
20. HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation. Kim SJ; Jung KH; Yan HH; Son MK; Fang Z; Ryu YL; Lee H; Lim JH; Suh JK; Kim J; Lee S; Hong S; Hong SS Oncotarget; 2015 Jan; 6(3):1507-18. PubMed ID: 25483100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]